JP2629542B2 - 抗腫瘍性インドロピロロカルバゾール誘導体 - Google Patents

抗腫瘍性インドロピロロカルバゾール誘導体

Info

Publication number
JP2629542B2
JP2629542B2 JP4336560A JP33656092A JP2629542B2 JP 2629542 B2 JP2629542 B2 JP 2629542B2 JP 4336560 A JP4336560 A JP 4336560A JP 33656092 A JP33656092 A JP 33656092A JP 2629542 B2 JP2629542 B2 JP 2629542B2
Authority
JP
Japan
Prior art keywords
group
compound
formula
lower alkyl
carboxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP4336560A
Other languages
English (en)
Japanese (ja)
Other versions
JPH06128283A (ja
Inventor
勝久 小尻
久雄 近藤
浩治 荒川
満 大久保
寛之 須田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Priority to JP4336560A priority Critical patent/JP2629542B2/ja
Publication of JPH06128283A publication Critical patent/JPH06128283A/ja
Application granted granted Critical
Publication of JP2629542B2 publication Critical patent/JP2629542B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Silicon Polymers (AREA)
JP4336560A 1991-11-29 1992-11-24 抗腫瘍性インドロピロロカルバゾール誘導体 Expired - Fee Related JP2629542B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4336560A JP2629542B2 (ja) 1991-11-29 1992-11-24 抗腫瘍性インドロピロロカルバゾール誘導体

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP34191691 1991-11-29
JP3-341916 1991-11-29
JP4-69269 1992-02-18
JP6926992 1992-02-18
JP25730692 1992-09-01
JP4-257306 1992-09-01
JP4336560A JP2629542B2 (ja) 1991-11-29 1992-11-24 抗腫瘍性インドロピロロカルバゾール誘導体

Publications (2)

Publication Number Publication Date
JPH06128283A JPH06128283A (ja) 1994-05-10
JP2629542B2 true JP2629542B2 (ja) 1997-07-09

Family

ID=27300000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4336560A Expired - Fee Related JP2629542B2 (ja) 1991-11-29 1992-11-24 抗腫瘍性インドロピロロカルバゾール誘導体

Country Status (27)

Country Link
EP (1) EP0545195B1 (enExample)
JP (1) JP2629542B2 (enExample)
KR (1) KR100275976B1 (enExample)
AT (1) ATE130617T1 (enExample)
AU (1) AU650376B2 (enExample)
BG (1) BG61036B1 (enExample)
CA (1) CA2083534C (enExample)
CZ (1) CZ287304B6 (enExample)
DE (1) DE69206242T2 (enExample)
DK (1) DK0545195T3 (enExample)
DZ (1) DZ1634A1 (enExample)
ES (1) ES2079774T3 (enExample)
FI (1) FI106864B (enExample)
GR (1) GR3018527T3 (enExample)
HU (3) HU9203754D0 (enExample)
IL (1) IL103844A (enExample)
MX (1) MX9206847A (enExample)
MY (1) MY114655A (enExample)
NO (1) NO178929C (enExample)
NZ (1) NZ245203A (enExample)
PL (1) PL171468B1 (enExample)
RO (1) RO113469B1 (enExample)
RU (1) RU2117671C1 (enExample)
SA (1) SA93130351B1 (enExample)
TW (1) TW224469B (enExample)
WO (1) WO1993011145A1 (enExample)
YU (1) YU48963B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2230433T3 (es) * 1994-05-09 2005-05-01 Banyu Pharmaceutical Co., Ltd. Procedimientos para la preparacion de derivados de indolopirrolocarbazol.
WO1995030682A1 (en) * 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyprolocarbazole derivative
WO1995034663A1 (en) * 1994-06-13 1995-12-21 Banyu Pharmaceutical Co., Ltd. Gene coding for glycosyltransferase and use thereof
AU3086495A (en) * 1994-08-02 1996-03-04 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazoles
US5591855A (en) * 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
US5594009A (en) * 1994-10-14 1997-01-14 Cephalon, Inc. Fused pyrrolocarbazoles
US5475110A (en) * 1994-10-14 1995-12-12 Cephalon, Inc. Fused Pyrrolocarbazoles
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
AU6836696A (en) * 1995-09-05 1997-03-27 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5616724A (en) * 1996-02-21 1997-04-01 Cephalon, Inc. Fused pyrrolo[2,3-c]carbazole-6-ones
BR9711306A (pt) * 1996-08-22 1999-08-17 Bristol Myers Squibb Co Amino a-Úcar citotÄxico e derivados de a-Úcar correlatos de indolopirrolocarbazÄis
GB9811624D0 (en) * 1998-05-29 1998-07-29 Merck Sharp & Dohme Therapeutic use
US6013646A (en) * 1998-07-02 2000-01-11 Bayer Corporation Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
WO2004083228A1 (ja) 1999-09-10 2004-09-30 Katsuhisa Kojiri インドロピロロカルバゾール誘導体及び抗腫瘍剤
FR2801054B1 (fr) * 1999-11-17 2003-06-13 Adir Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6790836B2 (en) 2000-02-24 2004-09-14 Banyu Pharmaceutical Co., Ltd. Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6555677B2 (en) 2000-10-31 2003-04-29 Merck & Co., Inc. Phase transfer catalyzed glycosidation of an indolocarbazole
IL157909A0 (en) 2001-03-22 2004-03-28 Bristol Myers Squibb Co Indolopyrrolocarbazole derivatives and pharmaceutical compositions containing the same
US6559299B2 (en) 2001-03-29 2003-05-06 Merck & Co., Inc. Preparation and isolation of indolocarbazole glycosides
AU2002335472B8 (en) * 2002-03-26 2007-12-20 Banyu Pharmaceutical Co., Ltd. Combined use of antitumor indolopyrrolocarbazole derivative and other antitumor agent
CA2398828A1 (en) 2002-08-09 2004-02-09 Merck & Co., Inc. A pharmaceutical composition containing an indolopyrrolocarbazole derivative
EP1541582A1 (en) * 2002-08-23 2005-06-15 Banyu Pharmaceutical Co., Ltd. Process for producing indolopyrrolocarbazole derivative
AU2003248103A1 (en) * 2003-07-24 2005-02-14 Banyu Pharmaceutical Co., Ltd Indolopyrrolocarbazole derivative and antitumor agent
AU2004272457A1 (en) * 2003-09-16 2005-03-24 Banyu Pharmaceutical Co., Ltd. Novel indolopyrrolocarbazole derivative with antitumor activity
US7169802B2 (en) 2003-12-23 2007-01-30 Cephalon, Inc. Fused pyrrolocarbazoles
US7241779B2 (en) 2003-12-23 2007-07-10 Cephalon, Inc. Fused pyrrolocarbazoles
RU2255089C1 (ru) * 2003-12-26 2005-06-27 Закрытое акционерное общество "АСГЛ-Исследовательские Лаборатории" Производные гликозидов индоло[2,3-а]пирроло[3,4-с]карбазол-5,7-дионов, обладающие цитотоксической и противоопухолевой активностью
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
CN103965204B (zh) 2008-11-19 2016-09-07 赛福伦公司 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Rebeccamycin analogs, their production and pharmaceutical compositions containing them
JPH0725787B2 (ja) * 1990-03-06 1995-03-22 ブリストル−マイヤーズ スクイブ カンパニー 臭化物前駆物質物質供給によるレベカマイシン類似体
WO1992018507A1 (en) * 1991-04-11 1992-10-29 Schering Corporation Anti-tumor and anti-psoriatic agents

Also Published As

Publication number Publication date
NO924593L (no) 1993-06-01
MY114655A (en) 2002-12-31
PL304729A1 (en) 1995-01-09
JPH06128283A (ja) 1994-05-10
CZ350892A3 (en) 1993-10-13
YU48963B (sh) 2003-01-31
BG61036B1 (bg) 1996-09-30
NO178929C (no) 1996-07-03
IL103844A (en) 1997-09-30
EP0545195B1 (en) 1995-11-22
RO113469B1 (ro) 1998-07-30
GR3018527T3 (en) 1996-03-31
YU102692A (sh) 1996-02-19
HU217611B (hu) 2000-03-28
EP0545195A1 (en) 1993-06-09
NZ245203A (en) 1997-07-27
NO924593D0 (no) 1992-11-27
WO1993011145A1 (en) 1993-06-10
NO178929B (no) 1996-03-25
PL171468B1 (pl) 1997-05-30
DE69206242D1 (de) 1996-01-04
HU9203754D0 (en) 1993-03-29
CZ287304B6 (cs) 2000-10-11
AU650376B2 (en) 1994-06-16
SA93130351B1 (ar) 2005-10-16
HU211254A9 (en) 1995-11-28
DK0545195T3 (da) 1995-12-18
ES2079774T3 (es) 1996-01-16
ATE130617T1 (de) 1995-12-15
FI925422A0 (fi) 1992-11-27
IL103844A0 (en) 1993-04-04
KR930010039A (ko) 1993-06-21
DE69206242T2 (de) 1996-03-28
KR100275976B1 (ko) 2001-02-01
MX9206847A (es) 1993-06-30
DZ1634A1 (fr) 2002-02-17
FI925422L (fi) 1993-05-30
RU2117671C1 (ru) 1998-08-20
BG97970A (bg) 1994-04-29
AU2963792A (en) 1993-06-03
CA2083534C (en) 2003-01-28
FI106864B (fi) 2001-04-30
CA2083534A1 (en) 1993-05-30
TW224469B (enExample) 1994-06-01
HUT65699A (en) 1994-07-28

Similar Documents

Publication Publication Date Title
EP0545195B1 (en) Indolopyrrolocarbazole derivatives
US5591842A (en) Indolopyrrolocarbazole derivatives
US5668271A (en) Indolopyrrolocarbazole derivatives
US5589365A (en) Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
JPH0662663B2 (ja) デスアザプリン―ヌクレオシド―誘導体
FI63946B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 5'deoxi-5-fluorcytidin och 5'-deoxi-5-fluor-uridin
CA2102782C (en) 2-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents
JPH0637394B2 (ja) 腫瘍治療剤
Revankar et al. Synthesis and antiviral/antitumor activities of certain 3-deazaguanine nucleosides and nucleotides
Kassem et al. Design, synthesis and anticancer activity of new thiazole-tetrazole or triazole hybrid glycosides targeting CDK-2 via structure-based virtual screening
WO1991018003A1 (fr) Derive antitumoral de be-13793c
Kazimierczuk et al. Synthesis and cytotoxicity of deoxyadenosine analogs: isomer distribution in the sodium salt glycosylation of 2, 6-disubstituted purines
RU2548045C1 (ru) N-ГЛИКОЗИДЫ ИНДОЛО[2,3-a]ПИРРОЛО[3,4-c]КАРБАЗОЛОВ, ОБЛАДАЮЩИЕ ПРОТИВООПУХОЛЕВОЙ АКТИВНОСТЬЮ
Chu et al. Nucleosides. 117. Synthesis of 4‐oxo‐8‐(β‐D‐ribofuranosyl)‐3H‐pyrazolo [1, 5‐a]‐1, 3, 5‐triazine (OPTR) via 3‐amino‐2N‐carbamoyl‐4‐(β‐D‐ribofuranosyl) pyrazole (ACPR) derivatives
Kondo et al. Aplysidine, a new nucleoside from the Okinawan marine sponge Aplysina Sp.
Komiotis et al. Biologically Important Nucleosides: A General Method for the Synthesis of Unsaturated Ketonucleosides of Uracil and its Analogs
Cristalli et al. 3, 7-Dideazapurine nucleosides. Synthesis and antitumor activity of 1-deazatubercidin and 2-chloro-2'-deoxy-3, 7-dideazaadenosine
Györgydeák et al. Cyclization reactions of N1-(glycopyranosylamino) guanidines
Kazimierczuk et al. Studies on Improved Synthesis of 2'-Deoxyribonucleosides of Pyridazine Derivatives
Seela et al. Synthesis of 3, 7-dideaza-2′-deoxyadenosine and related pyrrolo [3, 2-c] pyridine 2′-deoxyribo-and 2′, 3′-dideoxyribonucleosides
Schmidt et al. Purine nucleosides. XXXI. Directive effect which certain exocyclic substituents at C-8 of adenine have on the site of ribosylation
AU2004259289A1 (en) Indolopyrrolocabazole derivative and antitumor agent
CA2723079A1 (en) Novel triazole derivatives, their preparation and their application in therapeutics
PL172609B1 (en) Method of obtaining derivatives of indolopyrrolocarbasole
SI7713022A8 (sl) Postopek za pridobivanje 5’-dez0ksi-5-flu0rcitidina oziroma 5’-dez0ksi-5-flu0rcitidina

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080418

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090418

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100418

Year of fee payment: 13

LAPS Cancellation because of no payment of annual fees